← Browse by Condition
Medical Condition
in stent restenosis
Total Trials
3
Recruiting Now
3
Trial Phases
Phase 4
ClinicalMetric tracks all active clinical trials for in stent restenosis sourced from ClinicalTrials.gov. Each listing includes the NCT identifier, current recruitment status, phase, primary endpoints, sponsor, estimated enrollment, and participating countries — updated daily as new studies open and status changes.
- Recruiting trials currently enrolling participants, with eligibility criteria and age requirements
- Phase 1–4 studies from early safety trials to post-marketing surveillance
- NIH, pharmaceutical sponsor, and academic medical center studies worldwide
- AI-powered plain-language summary available for every trial listing
Trial Phases
Phase 4 1
Top Sponsors
1 trial
1 trial
1 trial
NCT06090890 Phase 4
Recruiting
Anti-inflammatory Therapy for Recurrent In-stent Restenosis
Enrollment
252 pts
Location
China
Sponsor
Fu Wai Hospital, Beijing, Chin...
NCT07297641
Recruiting
Intravascular Imaging-Guided Versus Angiography- Guided PCI in Patients With DES-ISR
Enrollment
1,500 pts
Location
China
Sponsor
Nanjing First Hospital, Nanjin...
NCT05908331
Recruiting
MagicTouch for Treatment of In-Stent Restenosis in Coronary Artery Lesions
Enrollment
492 pts
Location
United States
Sponsor
Concept Medical Inc.
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: April 2026 · Data Methodology